fda glp-1 compounding enforcement news october 2025 Ozempic's patent problem: how Novo Nordisk lost control of a blockbuster drug. ๐ Demand for weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Compounded Semaglutide & Tirzepatide 2025:
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 8 - Aug 13

























